Coronaviridae

COVID-19 Pandemic Will Force Companies Around the World to Radically Rethink How They Operate and Embrace Technological Investment

Retrieved on: 
Thursday, March 19, 2020
Articles, Coronaviridae, Global health, Pandemic, Coronavirus, Influenza A virus subtype H1N1

OYSTER BAY, N.Y., March 19, 2020 /PRNewswire/ -- The Coronavirus outbreak and the worldwide reaction to the pandemic will force companies to radically rethink how they operate and embrace technological investment, states global tech market advisory firm, ABI Research.

Key Points: 
  • OYSTER BAY, N.Y., March 19, 2020 /PRNewswire/ -- The Coronavirus outbreak and the worldwide reaction to the pandemic will force companies to radically rethink how they operate and embrace technological investment, states global tech market advisory firm, ABI Research.
  • Analysts also offer recommendations to weather the storm and strategies to help companies rebound and prosper after the pandemic has slowed.
  • "To effect change, there must be a stimulation of a magnitude that means companies cannot do anything but make bold decisions to survive.
  • For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com .

COVID-19 Pandemic Will Force Companies Around the World to Radically Rethink How They Operate and Embrace Technological Investment

Retrieved on: 
Thursday, March 19, 2020
Articles, Coronaviridae, Global health, Pandemic, Coronavirus, Influenza A virus subtype H1N1

OYSTER BAY, New York, March 19, 2020 /PRNewswire/ -- The Coronavirus outbreak and the worldwide reaction to the pandemic will force companies to radically rethink how they operate and embrace technological investment, states global tech market advisory firm, ABI Research.

Key Points: 
  • OYSTER BAY, New York, March 19, 2020 /PRNewswire/ -- The Coronavirus outbreak and the worldwide reaction to the pandemic will force companies to radically rethink how they operate and embrace technological investment, states global tech market advisory firm, ABI Research.
  • Analysts also offer recommendations to weather the storm and strategies to help companies rebound and prosper after the pandemic has slowed.
  • "To effect change, there must be a stimulation of a magnitude that means companies cannot do anything but make bold decisions to survive.
  • For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com .

KPA Releases Free COVID-19 Coronavirus Resource Center for Businesses to Navigate Workplace Concerns

Retrieved on: 
Thursday, March 19, 2020
Battles of the Korean War, Coronaviridae, Animal virology, Coronavirus, Battles, Military history of Korea, Military operations, Battle of Pusan Perimeter, North Gyeongsang Province

LAFAYETTE, Colo., March 19, 2020 /PRNewswire-PRWeb/ --Today, KPA released a free COVID-19 Coronavirus Resources Center for employers needing information to help keep their workforce healthy and safe.

Key Points: 
  • LAFAYETTE, Colo., March 19, 2020 /PRNewswire-PRWeb/ --Today, KPA released a free COVID-19 Coronavirus Resources Center for employers needing information to help keep their workforce healthy and safe.
  • The Resource Center includes five safety training courses, several webinars, checklists, and the latest updates from KPA's team of experts in Environmental, Health, and Safety (EHS) and Human Resources.
  • "KPA is committed to helping organizations keep their workforce healthy during the Coronavirus pandemic," said Chris Fanning, President and CEO of KPA.
  • As society continues to navigate the Coronavirus pandemic, KPA will continue to update the Resource Center with information and valuable resources.

19Check.com Offering Free Online Coronavirus Assessments in Canada

Retrieved on: 
Thursday, March 19, 2020
Technology, Infectious diseases, Consulting, Professional services, Software, Internet, Pharmaceutical, Health, Retail, Online Retail, Coronaviridae, Articles, Animal virology, Assistive technology, Telehealth, Coronavirus, Technology

Locke Bio today launched 19Check.com , a free telehealth tool to help people exhibiting coronavirus symptoms connect with medical professionals via teleconference to determine the likelihood of having coronavirus.

Key Points: 
  • Locke Bio today launched 19Check.com , a free telehealth tool to help people exhibiting coronavirus symptoms connect with medical professionals via teleconference to determine the likelihood of having coronavirus.
  • The tool also includes free resources on recognizing symptoms, protecting others, and preventing the spread of the virus.
  • In 2018 Forbes named her to the Healthcare "30 under 30" list, and she was the youngest partner at Cervin Ventures.
  • 19Check is a service of Locke Bio , which provides telemedicine and prescription delivery services throughout Canada.

US ECOLOGY PROVIDING DECONTAMINATION RESPONSE TO CORONAVIRUS (COVID 19) OUTBREAK

Retrieved on: 
Thursday, March 19, 2020
Hygiene, Coronaviridae, Animal virology, Coronavirus, Decontamination, Health, Safety, Articles, Security

BOISE, Idaho, March 19, 2020 (GLOBE NEWSWIRE) -- US Ecology, Inc. (US Ecology or the Company), in response to the COVID-19 Coronavirus outbreak, offers a comprehensive range of decontamination response and disposal services to customers, providing safe solutions for all disinfecting and decontamination needs to combat the spread of COVID-19.

Key Points: 
  • BOISE, Idaho, March 19, 2020 (GLOBE NEWSWIRE) -- US Ecology, Inc. (US Ecology or the Company), in response to the COVID-19 Coronavirus outbreak, offers a comprehensive range of decontamination response and disposal services to customers, providing safe solutions for all disinfecting and decontamination needs to combat the spread of COVID-19.
  • With a nationwide footprint of disposal facilities and service centers in place, US Ecology stands ready to serve new and existing customers.
  • US Ecologys broad range of decontamination services include biological and infectious response, cleanup and disposal, blood borne pathogen cleanup and infectious waste management.
  • To enlist US Ecology's Decontamination Response and Disposal Services for the Coronavirus (COVID-19) please call the Emergency Response hotline at (800) 899-4672, contact a sales representative, or visit: https://www.usecology.com/contact-us .

COVID-19 Patients Should Avoid THC

Retrieved on: 
Thursday, March 19, 2020
Viruses, Infectious diseases, Animal virology, Microbiology, Coronaviridae, Influenza, RTT, Coronavirus, Viral phylodynamics, Influenza A virus subtype H5N1

We know that the epidemiology of COVID-19 is similar to the influenza virus and has a similar disease presentation.

Key Points: 
  • We know that the epidemiology of COVID-19 is similar to the influenza virus and has a similar disease presentation.
  • And we know that in studies1 where THC was administered to mice with influenza, we saw an increase in viral loads and a decrease in the immune system to fight off the virus.
  • It stands to reason that the same would hold true for Coronavirus and THC consumption could diminish the immune system of someone infected with the virus, said Aurelius Data CEO Julie Armstrong.
  • Aurelius Data has prepared a brief survey to better inform patients on how cannabis consumption affects viral infections.

Accuform Offers Free Coronavirus Prevention Poster for Business Facilities

Retrieved on: 
Thursday, March 19, 2020
Coronaviridae, Occupational safety and health, Lockout-tagout, Coronavirus, Prevention, Articles

BROOKSVILLE, Fla., March 18, 2020 /PRNewswire/ --In response to the severity of the current Coronavirus (COVID-19) pandemic outbreak, safety identification manufacturer, Accuform is offering a free prevention tips poster - available to the public and business facilities for downloading, sharing, printing and posting in facilities to help reduce the spreading of the virus.

Key Points: 
  • BROOKSVILLE, Fla., March 18, 2020 /PRNewswire/ --In response to the severity of the current Coronavirus (COVID-19) pandemic outbreak, safety identification manufacturer, Accuform is offering a free prevention tips poster - available to the public and business facilities for downloading, sharing, printing and posting in facilities to help reduce the spreading of the virus.
  • The preventative measures on the poster are sourced from the Centers for Disease Control and Prevention for accuracy of information.
  • The poster is offered as a free resource to address the specificities of Coronavirus prevention and compliments the germ prevention related products many Accuform customers rely on to keep their workforce informed, protected and motivated.
  • Since 1976, Accuform has been leading the safety identification industry as a manufacturer of facility safety signs, tags, labels, banners, lockout/tagout, and more.

QIAGEN launches QIAstat-Dx test kit for detection of SARS-CoV-2 coronavirus in Europe following CE marking

Retrieved on: 
Wednesday, March 18, 2020
Biotechnology, Infectious diseases, Health, Pharmaceutical, Clinical trials, Viruses, Nidovirales, Coronaviridae, Zoonoses, Animal virology, Coronavirus, Severe acute respiratory syndrome-related coronavirus, CoV, Qiagen, Severe acute respiratory syndrome, SARS coronavirus main proteinase, Bat SARS-like coronavirus WIV1

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has obtained CE marking for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test to be sold as an in vitro diagnostic (IVD) for the detection of SARS-CoV-2.

Key Points: 
  • QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has obtained CE marking for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test to be sold as an in vitro diagnostic (IVD) for the detection of SARS-CoV-2.
  • The QIAstat-Dx Respiratory SARS-CoV-2 Panel is a multiplexed nucleic acid test that evaluates samples such as nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections.
  • The newly approved panel includes assays targeting two genes used to detect the pathogen behind the disease, Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2).
  • We are pleased to launch the QIAstat-Dx SARS-CoV-2 test kits in Europe for clinical laboratories.

Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus

Retrieved on: 
Wednesday, March 18, 2020
Viruses, Coronaviridae, Animal virology, In Saudi Arabia, Middle East respiratory syndrome, Emergency Use Authorization, Food and Drug Administration, Coronavirus, Middle East respiratory syndrome-related coronavirus, CoV, Severe acute respiratory syndrome-related coronavirus, Abt

ABBOTT PARK, Ill., March 18, 2020 /PRNewswire/ --Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular test for novel coronavirus (COVID-19).

Key Points: 
  • ABBOTT PARK, Ill., March 18, 2020 /PRNewswire/ --Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular test for novel coronavirus (COVID-19).
  • Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the U.S.
  • Abbott will be working with health systems and government authorities to deploy additional m2000 systems where they are needed.
  • Abbott has long been a global leader in infectious disease testing, including the development of the first HIV test.

Coronavirus Accentuates Existing Problems in America’s Health Care System

Retrieved on: 
Wednesday, March 18, 2020
Software, General Health, Professional services, Philanthropy, Technology, Infectious diseases, Hospitals, Foundation, Insurance, Human resources, Other Technology, Other Philanthropy, Health, Viruses, Zoonoses, Coronaviridae, In Saudi Arabia, Animal virology, Coronavirus, Middle East respiratory syndrome

However, this comes as no surprise to those with a career in health care, like James Napoli, JD, CEO of Medliminal.

Key Points: 
  • However, this comes as no surprise to those with a career in health care, like James Napoli, JD, CEO of Medliminal.
  • Medliminals Senior Director of Hospital Division, Brian Echols, is continuing to work with his team to provide health care consumers with the newest innovations in medical cost containment.
  • Medliminal is closely following recommendations from the CDC and CMS regarding coding and billing guidance for health care encounters related to the Coronavirus outbreak, Mr. Echols disclosed.
  • With years of experience and their team of experts, Medliminal has positioned itself to be at the forefront in the containment of health care costs associated with the Coronavirus.